Determination of Posaconazole in Plasma/Serum by High-Performance Liquid Chromatography with Fluorescence Detection
Author:
Open Access
- 8 May 2017
- journal article
- research article
- Published by MDPI AG in Separations
- Vol. 4 (2) , 16
Abstract
A sensitive high-performance liquid chromatographic (HPLC) method is described for the determination of posaconazole in human plasma/serum. The method is based on a single dilution step by treating the sample with methanol, and followed by the direct injection of the sample into the HPLC system. Posaconazole and internal standard ketoconazole in the methanol extract are subsequently analyzed by using a fluorescence (FL) detector at optimized wavelengths (excitation 245 nm and emission 380 nm). The method achieves a linear detector response for peak height measurements over the concentration range of 0.1–10 µg/mL which adequately covers the therapeutic range for appropriate patient monitoring. The chromatographic time is less than 8 min per injection, an improvement over most published HPLC/FL or HPLC/UV methods. The method’s limit of quantitation, linearity, imprecision, and accuracy met all criteria required by the Guidance for Industry Bioanalytical Method Validation. In comparison to other published methods, the current method would be of interest to analytical and clinical laboratories because it employs simple, rapid, and cost-effective procedures.Keywords
Funding Information
- Department of Pathology and Laboratory Medicine, Cincinnati Children’s Hospital Medical Center
This publication has 38 references indexed in Scilit:
- Multicenter Study of Posaconazole Therapeutic Drug Monitoring: Exposure-Response Relationship and Factors Affecting ConcentrationAntimicrobial Agents and Chemotherapy, 2012
- Development and validation of a new method to simultaneously quantify triazoles in plasma spotted on dry sample spot devices and analysed by HPLC-MSJournal of Antimicrobial Chemotherapy, 2012
- Posaconazole Exposure-Response Relationship: Evaluating the Utility of Therapeutic Drug MonitoringAntimicrobial Agents and Chemotherapy, 2012
- Measurement of Posaconazole, Itraconazole, and Hydroxyitraconazole in Plasma/Serum by High-Performance Liquid Chromatography With Fluorescence DetectionTherapeutic Drug Monitoring, 2011
- Ultra-Performance Liquid Chromatography Mass Spectrometry and Sensitive Bioassay Methods for Quantification of Posaconazole Plasma Concentrations after Oral DosingAntimicrobial Agents and Chemotherapy, 2010
- Clinical pharmacodynamics and pharmacokinetics of the antifungal extended‐spectrum triazole posaconazole: an overviewBritish Journal of Clinical Pharmacology, 2010
- Development, Validation, and Routine Application of a High-Performance Liquid Chromatography Method Coupled with a Single Mass Detector for Quantification of Itraconazole, Voriconazole, and Posaconazole in Human PlasmaAntimicrobial Agents and Chemotherapy, 2010
- Review of the Basic and Clinical Pharmacology of Sulfobutylether-β-Cydodextrin (SBECD)Journal of Pharmaceutical Sciences, 2010
- A high-throughput LC–MS/MS method for the quantitation of posaconazole in human plasma: Implementing fused core silica liquid chromatographyJournal of Pharmaceutical and Biomedical Analysis, 2009
- Simultaneous Determination of Voriconazole and Posaconazole Concentrations in Human Plasma by High-Performance Liquid ChromatographyAntimicrobial Agents and Chemotherapy, 2009